Peptides Module III Peptides Module IV 7:30 am Peptide Overview and Cancer Treatments William Seeds, MD 8:00 am Cancer Nutrition and Labs James LaValle, RPh 9:30 am Break 10:00 am Peptides Target Cell Cycle Andrew Heyman MD 11:00 am Tumor Targeting Peptides Andrew Heyman MD 12:00 pm Lunch 1:30 pm Cell Penetrating Peptides Tumor Targeting Peptides William Seeds, MD 3:30 pm Break 4:00 pm Peptides Target Tumor Suppressor Protein Peptide Target Transcription Factors Nima Alavi 6:00 pm Close of Session 7:30 am Anti-Aging Protocols: Final Assumptions William Seeds, MD 8:30 am Laboratory Initial Evaluation and Follow Up James LaValle, RPh 9:30 am Break 10:00 am Peptides in the future, Breakthroughs in Peptide Understanding James LaValle, RPh 11:00 am Nutrition and Supplement Protocol James LaValle, RPh 12:00 pm Lunch 1:30 pm Type I and Type II Ground Breaking Origin William Seeds, MD 3:30 pm Break 4:00 pm Peptide Treatment for Acute and Chronic Infections Kent Holtorf, MD 6:00 pm Close of Session 7:30 am Nutrients for Type 2 Diabetes James LaValle, RPh 9:30 am Break 10:00 am Peptides in Treatment of Chronic Fatigue Syndrome William Seeds, MD 12:00 pm Lunch - Sponsored by Legally Mine 1:30 pm Rheumatoid Arthritis, SLE, Psoriasis and PA, Ankylosing Spondylitis William Seeds, MD 3:30 pm Break 4:00 pm Nutrition and Supplements for RA, SLE, PA, AS James LaValle, RPh 5:00 pm Case Studies: Infections and Metabolic Disease William Seeds, MD James LaValle, RPh Kent Holtorf, MD Andrew Heyman, MD Kathy O'Neil-Smith, MD 6:00 pm Close of Session 7:30 am Inflammatory Bowel Disease, Chrons Disease, Ulcerative Colitis Kathy O'Neil-Smith, MD, FAARM 8:30 am Nutrition and Supplements for GI Tract James LaValle, RPh 9:30 am Break 10:00 am Neuroinflammation Andrew Heyman, MD 11:00 am Dementia & Autism William Seeds, MD 12:00 pm Lunch 1:30 pm Amyotrophic Lateral Sclerosis, Multiple Sclerosis Kathy O'Neil-Smith, MD 2:30 pm Alzheimers, Parkinson Kathy O'Neil-Smith, MD 3:30 pm Break 4:00 pm Nutrition and Supplements: Neuronal Disease James LaValle, RPh 5:00 pm Case Studies: Peptides and Neuronal Disease Kathy O'Neil-Smith, MD, FAARM William Seeds, MD James LaValle, RPh Andrew Heyman, MD 6:00 pm Close of Session 3355 Las Vegas Blvd
In some embodiments, the formulations or compositions are substantially free of microorganisms
Does BPC 157 Build Muscle
Sensfuss, Development of cagrilintide, a longacting amylin analogue, J
a-MSH influences a wide variety of body functions, including helping to modulate immune responses and reduce inflammation
